O-I Glass (OI) Q3 2026 Earnings Call Transcript

O-I Glass reported Q3 adjusted EBITDA of $234 million, down from $329 million a year earlier, and an adjusted loss of $0.09 per share versus $0.48 in profit; Europe segment operating profit fell to $2 million from $95 million. Management cut 2026 adjusted EBITDA guidance to $925–$950 million from $1.0–$1.1 billion and expects about $300 million of full-year free-cash-flow usage, citing weaker demand and elevated energy and freight costs. Year-end net leverage is expected at 4.5–5.0x; management expects improved earnings and positive free cash flow in 2027, but has not yet issued formal 2027 guidance.

Analysis

The key issue is not simply European energy inflation: it is whether O-I can convert plant-level efficiency into realized price while Southern European wine capacity remains structurally surplus. Higher utilization in O-I’s own network does not by itself restore pricing power if rival capacity is still chasing volume. Management’s expected positive net price in 2027 is therefore the most important—and least evidenced—piece of the recovery case; verify contract reset timing, price realization versus input-cost inflation, and regional volumes before crediting it.

The proposed plant closure and Fit-to-Win gains may improve the cost base, but execution has a working-capital and cash cost: inventory is elevated, restructuring consumes cash, and leverage is high. This makes the equity more sensitive to any further EBITDA miss than headline liquidity suggests. Energy hedges reduce near-term volatility, but also limit the benefit if prices fall; they do not resolve demand or freight exposure. The planned Brazil furnace adds a second-order tension: growth investment could capture attractive regional demand, but competes with deleveraging while free cash flow is under pressure.

Near term, the guidance cut and weak European profit warrant caution, but chasing a post-earnings decline risks selling after the obvious reset. Over 1–3 months, watch the February outlook for evidence that price recovery, inventory reduction, and lower restructuring cash costs are translating into cash—not just EBITDA. Over 6–18 months, a credible European turnaround could produce substantial operating leverage; failure would make portfolio actions or balance-sheet measures more relevant. Management’s 2027 framework is conditional, not yet demonstrated.

Key Decisions for Investors

• Keep O-I underweight; avoid adding on the earnings-day reaction alone. Consider a defined-risk put spread only if the shares fail to stabilize and the next outlook confirms that European price realization is lagging cost inflation. Without current price and implied-volatility data, do not set strikes or size from this transcript.
• Treat the February 2027 update as the key catalyst. Upgrade the thesis only if management shows measurable net-price improvement, inventory days trending down, and positive free cash flow; a higher EBITDA outlook without working-capital conversion is insufficient.
• Monitor European wine-market capacity and O-I’s regional shipment/price mix. Persistent Southern Europe discounting, or another downward guidance revision, would falsify the recovery thesis and support maintaining or increasing the underweight.
• Do not interpret liquidity headroom as proof that leverage is benign. Track year-end net leverage, covenant headroom, restructuring cash outlays, and any portfolio action; a strategic sale could help deleveraging but is not yet a bankable catalyst.